Changes in the Cytokine Profile of Lupus-prone Mice (NZB/NZW)F1 Induced by Plasmodium Chabaudi and Their Implications in the Reversal of Clinical Symptoms

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2000 Jan 13

PMID 10632672

Citations 4

Authors

M N Sato

P Minoprio

S Avrameas

T Ternynck

Affiliations

Soon will be listed here.

Abstract

We have previously observed that aged lupus-prone (NZB/NZW)Fl (BWF1) mice when infected with Plasmodium chabaudi show an improvement in their clinical lupus-like symptoms. In order to study the mechanisms involved in the long-lasting protective effect of the P. chabaudi infection in lupus-prone mice we analysed specific aspects of the cellular response, namely the profiles of cytokine mRNA expression and cytokine secretion levels in old BWF1 mice, in comparison with uninfected age-matched BWF1 mice and infected or uninfected BALB/c mice. Two months after infection, cells from BWF1 mice were stimulated with concanavalin A (Con A) and demonstrated a recovery of T cell responsiveness that reached the levels obtained with BALB/c cells. Old BWF1 mice showed high levels of interferon-gamma (IFN-gamma) and IL-5 production and correspondingly low levels of IL-2 and IL-4 secretion before infection with P. chabaudi. Infection did not modify the IFN-gamma levels of BWF1 T cells, whereas it considerably increased the secretion of the Th2-related cytokines IL-4, IL-5 and IL-10. In addition, only BWF1 T cells showed increased mRNA expression of tumour necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta). This counter-regulatory cytokine network of infected BWF1 mice may be involved in the improvement of their lupus symptoms. The results of our investigations using the complex model of P. chabaudi infection can be extended and, by using more restricted approaches, it may be possible to explain the multiple regulatory defects of lupus-prone mice.

Citing Articles

SLE: Another Autoimmune Disorder Influenced by Microbes and Diet?.

Mu Q, Zhang H, Luo X Front Immunol. 2015; 6:608.

PMID: 26648937 PMC: 4663251. DOI: 10.3389/fimmu.2015.00608.

The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.

Sela U, Sharabi A, Dayan M, Hershkoviz R, Mozes E Immunology. 2008; 128(1 Suppl):e395-405.

PMID: 19040426 PMC: 2753948. DOI: 10.1111/j.1365-2567.2008.02988.x.

Glomerulonephritis, Th1 and Th2: what's new?.

Tipping P, Kitching A Clin Exp Immunol. 2005; 142(2):207-15.

PMID: 16232206 PMC: 1809516. DOI: 10.1111/j.1365-2249.2005.02842.x.

Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Barabas A, Cole C, Barabas A, Lafreniere R Int J Exp Pathol. 2004; 85(6):321-34.

PMID: 15566429 PMC: 2517532. DOI: 10.1111/j.0959-9673.2004.00388.x.

References

Jacob C, McDevitt H . Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 1988; 331(6154):356-8. DOI: 10.1038/331356a0. View

Krug M, Berger S . First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol. 1987; 152:316-25. DOI: 10.1016/0076-6879(87)52036-5. View

Gordon C, Ranges G, Greenspan J, Wofsy D . Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol. 1989; 52(3):421-34. DOI: 10.1016/0090-1229(89)90157-8. View

Watanabe Y, Jacob C . Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell. J Immunol. 1991; 146(3):899-905. View

Fiorentino D, Zlotnik A, Vieira P, Mosmann T, Howard M, Moore K . IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991; 146(10):3444-51. View

Ternynck T, Falanga P, Unterkirscher C, Gregoire J, da Silva L, Avrameas S . Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int Immunol. 1991; 3(1):29-37. DOI: 10.1093/intimm/3.1.29. View

Hentati B, Ternynck T, Avrameas S, Payelle-Brogard B . Comparison of natural antibodies to autoantibodies arising during lupus in (NZB x NZW)F1 mice. J Autoimmun. 1991; 4(2):341-56. DOI: 10.1016/0896-8411(91)90029-c. View

Abrams J, Roncarolo M, Yssel H, Andersson U, Gleich G, Silver J . Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992; 127:5-24. DOI: 10.1111/j.1600-065x.1992.tb01406.x. View

Stevenson M, Tam M . Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin Exp Immunol. 1993; 92(1):77-83. PMC: 1554870. DOI: 10.1111/j.1365-2249.1993.tb05951.x. View

10.

Murphy E, Hieny S, Sher A, OGarra A . Detection of in vivo expression of interleukin-10 using a semi-quantitative polymerase chain reaction method in Schistosoma mansoni infected mice. J Immunol Methods. 1993; 162(2):211-23. DOI: 10.1016/0022-1759(93)90386-l. View

11.

Taylor-Robinson A, Phillips R, Severn A, Moncada S, Liew F . The role of TH1 and TH2 cells in a rodent malaria infection. Science. 1993; 260(5116):1931-4. DOI: 10.1126/science.8100366. View

12.

Avrameas S, Ternynck T . The natural autoantibodies system: between hypotheses and facts. Mol Immunol. 1993; 30(12):1133-42. DOI: 10.1016/0161-5890(93)90160-d. View

13.

Minoprio P, El Cheikh M, Murphy E, Hontebeyrie-Joskowicz M, COFFMAN R, Coutinho A . Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol. 1993; 151(8):4200-8. View

14.

Merino R, Iwamoto M, Fossati L, Izui S . Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. J Immunol. 1993; 151(11):6509-16. View

15.

Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M . Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994; 179(1):305-10. PMC: 2191319. DOI: 10.1084/jem.179.1.305. View

16.

Hamilton A, Lehuen A, Kearney J . Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int Immunol. 1994; 6(3):355-61. DOI: 10.1093/intimm/6.3.355. View

17.

Hentati B, Sato M, Payelle-Brogard B, Avrameas S, Ternynck T . Beneficial effect of polyclonal immunoglobulins from malaria-infected BALB/c mice on the lupus-like syndrome of (NZB x NZW)F1 mice. Eur J Immunol. 1994; 24(1):8-15. DOI: 10.1002/eji.1830240103. View

18.

Hardy R, Carmack C, Li Y, Hayakawa K . Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev. 1994; 137:91-118. DOI: 10.1111/j.1600-065x.1994.tb00660.x. View

19.

Chen Y, Inobe J, Weiner H . Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol. 1995; 155(2):910-6. View

20.

Sato M, Minoprio P, Avrameas S, Ternynck T . Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis. Immunology. 1995; 85(1):26-32. PMC: 1384020. View